| Revenue growth | FY26 -8% YoY; Q4 ₹235cr (-31% YoY). |
|---|---|
| Margins | FY26 EBITDA 31%; Q4 Gross Margin 56%. |
| Demand visibility | Strong visibility in CM segment; confirmed orders in select PI programs. |
| Management confidence | High for FY27; destocking in PI segment completed. |
Growth
FY26 Revenue: ₹947cr (-8% YoY); EBITDA: 31% (vs 37% FY25); Contrast Media grew 23% full year.
Outlook
Planned ₹1,040cr capex (₹1,000cr Vizag, ₹40cr Hyderabad); guiding for double-digit growth in Contrast Media for FY27.
Risks
PI/API segment revenue fell 35% due to customer destocking; pricing pressure from imports in artificial sweeteners.
Earnings Call filed with NSE, NSE: BLUEJET. Summary written with AI assistance from the document.
Blue Jet Healthcare Ltd: key numbers
- Share price
- ₹570.65
- Market cap
- ₹9,899 Cr
- Revenue (annual)
- ₹947.3 Cr
- Net profit (annual)
- ₹247.8 Cr
- P/E (TTM)
- 42.1×Sector 50.4×
- Promoter holding
- 73.15%-6.66% QoQ
- FII holding
- 0.63%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Blue Jet Healthcare Ltd
All →Blue Jet Healthcare Annual General Meeting
Blue Jet Healthcare held its 58th AGM, approving audited financials, a Re 1.20 dividend, and director re-appointments. No material amendments were noted.
Blue Jet Healthcare Investor Presentation: Key Takeaways
Blue Jet Healthcare reported Q1 FY27 revenue of INR 293 crores (+25% QoQ) and EBITDA of INR 98 crores. Management highlighted a shift toward higher-value PI and API verticals alongside significant upcoming capex.
Blue Jet Healthcare Earnings Call Transcript: Key Takeaways
Blue Jet Healthcare reported Q1 FY27 revenue of ₹2,931mn, up 25% QoQ but down 17% YoY. Management is focusing on capacity expansion and forward integration into advanced contrast media intermediates.
Blue Jet Healthcare Investor Presentation: Key Takeaways
Blue Jet Healthcare reported Q1 FY27 Revenue of ₹2,931mn, up 25% QoQ but down 17.4% YoY. Strategy focuses on expanding R&D and CDMO adjacencies.
Blue Jet Healthcare Q1 FY27 Results: Net Profit ₹78.3 Cr, Down 14.1% YoY
Blue Jet Healthcare Ltd reported revenue from operations of ₹293.1 Cr (-17.4% YoY) and net profit of ₹78.3 Cr (-14.1% YoY) for Q1 FY27.
- Key figure
- Net profit ₹78.3 Cr · -14.1% YoY
Blue Jet Healthcare Earnings Call: Key Takeaways
Blue Jet Healthcare reported FY26 revenue of ₹9,473 mn with 31% EBITDA margin. Strong growth in Contrast Media was offset by declines in Pharma Intermediates & API due to customer inventory normalization.